Supplement Firms Making Drug Claims Land On Fast Track To Notoriety At FDA
This article was originally published in The Tan Sheet
Executive Summary
FDA is compiling an ongoing list of “online advisory letters” to identify supplement firms that fail to respond within 30 days to notices about noncompliant claims. The agency anticipates spurring an uptick in NDI notifications by publishing a draft guidance by the end of the year.
You may also be interested in...
Supplement NDI Draft Guidance Discussions Snagged On Basic Criteria
FDA’s dietary supplement division is concerned that firms are not submitting NDI notifications in cases where they should be, while industry stakeholders assert the agency needs to clarify the criteria for determining which products should be the subject of notifications and what information is needed.
US Proposed OTC Hearing Aid Rule Inspired Soundly Founder To ‘Make This Process Easier’
In recent interview, CEO Blake Cadwell talked about Soundly’s business model and outlook for hearing aid marketplace after FDA's pending publication of rule aiming to make the devices more accessible. Firm since June has offered online testing and advice for customers about hearing aids best suited for their needs.